418 related articles for article (PubMed ID: 34769049)
1. Biomolecular Evaluation of Piceatannol's Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
Alessio N; Squillaro T; Lettiero I; Galano G; De Rosa R; Peluso G; Galderisi U; Di Bernardo G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769049
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Induction and Targeting of Senescent Mesenchymal Stromal Cells.
Gresham RCH; Kumar D; Copp J; Lee MA; Leach JK
Tissue Eng Part C Methods; 2022 Jun; 28(6):239-249. PubMed ID: 35438548
[TBL] [Abstract][Full Text] [Related]
3. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
Wong PF; Dharmani M; Ramasamy TS
Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
[TBL] [Abstract][Full Text] [Related]
4. Engineering osteoarthritic cartilage model through differentiating senescent human mesenchymal stem cells for testing disease-modifying drugs.
Wang N; He Y; Liu S; Makarcyzk MJ; Lei G; Chang A; Alexander PG; Hao T; Padget AM; de Pedro N; Menelaos T; Lin H
Sci China Life Sci; 2022 Feb; 65(2):309-327. PubMed ID: 34109475
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives.
Zhang M; Serna-Salas S; Damba T; Borghesan M; Demaria M; Moshage H
Mech Ageing Dev; 2021 Oct; 199():111572. PubMed ID: 34536446
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the discovery of senolytics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle aging, cellular senescence, and senotherapeutics: Current knowledge and future directions.
Englund DA; Zhang X; Aversa Z; LeBrasseur NK
Mech Ageing Dev; 2021 Dec; 200():111595. PubMed ID: 34742751
[TBL] [Abstract][Full Text] [Related]
8. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
Saleh T; Carpenter VJ
Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles from mesenchymal stromal cells: Therapeutic perspectives for targeting senescence in osteoarthritis.
Boulestreau J; Maumus M; Jorgensen C; Noël D
Adv Drug Deliv Rev; 2021 Aug; 175():113836. PubMed ID: 34166759
[TBL] [Abstract][Full Text] [Related]
10. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
11. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
Nehlin JO
Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-derived extracellular vesicles reduce senescence and extend health span in mouse models of aging.
Dorronsoro A; Santiago FE; Grassi D; Zhang T; Lai RC; McGowan SJ; Angelini L; Lavasani M; Corbo L; Lu A; Brooks RW; Garcia-Contreras M; Stolz DB; Amelio A; Boregowda SV; Fallahi M; Reich A; Ricordi C; Phinney DG; Huard J; Lim SK; Niedernhofer LJ; Robbins PD
Aging Cell; 2021 Apr; 20(4):e13337. PubMed ID: 33728821
[TBL] [Abstract][Full Text] [Related]
13. Chemical Strategies for the Detection and Elimination of Senescent Cells.
García-Fleitas J; García-Fernández A; Martí-Centelles V; Sancenón F; Bernardos A; Martínez-Máñez R
Acc Chem Res; 2024 May; 57(9):1238-1253. PubMed ID: 38604701
[TBL] [Abstract][Full Text] [Related]
14. New Horizons in cellular senescence for clinicians.
Witham MD; Granic A; Miwa S; Passos JF; Richardson GD; Sayer AA
Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37466640
[TBL] [Abstract][Full Text] [Related]
15. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
16. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
Nadeau S; Cheng A; Colmegna I; Rodier F
Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Senolytics in Cardiovascular Disease.
Dookun E; Passos JF; Arthur HM; Richardson GD
Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
[TBL] [Abstract][Full Text] [Related]
18. Effect of serum choice on replicative senescence in mesenchymal stromal cells.
Liu Y; Li YQ; Wang HY; Li YJ; Liu GY; Xu X; Wu XB; Jing YG; Yao Y; Wu CT; Jin JD
Cytotherapy; 2015 Jul; 17(7):874-84. PubMed ID: 25800776
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea-induced senescent peripheral blood mesenchymal stromal cells inhibit bystander cell proliferation of JAK2V617F-positive human erythroleukemia cells.
Bjelica S; Diklić M; Đikić D; Kovačić M; Subotički T; Mitrović-Ajtić O; Radojković M; Čokić VP; Santibanez JF
FEBS J; 2019 Sep; 286(18):3647-3663. PubMed ID: 31090259
[TBL] [Abstract][Full Text] [Related]
20. Senotherapeutics: emerging strategy for healthy aging and age-related disease.
Kim EC; Kim JR
BMB Rep; 2019 Jan; 52(1):47-55. PubMed ID: 30526770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
